BPH/LUTS/Sexual FunctionsEJHP-GLPVPNCT07819032
Long Term Evaluation of Ejaculatory Hood Preserving GreenLight Laser Photoselective Vaporization of the Prostate
An observational study of BPH/LUTS/Sexual Functions, run by Mansoura University at 1 site in Egypt.
Trial summary
long term evaluation of ejaculation preserving laser prostatectomy for BPH patients Read more about this study
- Who is it for?
- Ages 40 years and older, men only
- Conditions the study is for
- BPH/LUTS/Sexual Functions
- How many people
- 46 participants
- Where
- 1 siteEgypt
- Study dates
- 6 Jun 2024to 7 Sep 2026
- How long will I take part?
- 5 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Study population: BPH patients managed by green laser prostatectomy
Who may be able to join
- all patients who were previously managed by green laser PVP in the past 5 years in our center
Who cannot join
- death or patients who missed follow up
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Urology and Nephrology Center, Mnasoura University
Al Mansurah, Dakahlia Governorate, 35561
About this study
Official title: Ejaculatory Hood Preserving GreenLight Laser Photoselective Vaporization of the Prostate, A Test Against Time
long term evaluation of ejaculation preserving laser prostatectomy for BPH patients
Read the detailed description
We aimed to follow up our patients who were managed by ejaculation preserving GLPVP. we aimed to elucidate the long-term impact of EH preserving GL-PVP on both LUTS recurrence if any and the maintenance of adequate and satisfying ejaculatory functions 5 years after intervention compared to the last point of previous follow up (1 year after intervention).
- Conditions
- BPH/LUTS/Sexual Functions
- Keywords
- Ejaculatory Hood, laser prostatectomy, antegrade ejaculation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| standard green laser PVP | long term follow up impact of standard GL.PVP on both LUTS and sexual functions | |
| Ejaculatory hood preserving green laser PVP | long term follow up impact of standard GL.PVP on both LUTS and sexual functions |
What is being measured
The primary outcome is the main question the study is designed to answer.
International prostate symptom score at 5 years
the possible recurrence of lower urinary tract symptoms assessed by increased international prostate symptom score (higher score= recurrence).
Measured: 5 years after laser prostatectomy
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2026
- Study start6 Jun 2024
- Primary completion7 Sep 2026
- Study completion7 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for BPH/LUTS/Sexual FunctionsStudies of the same condition, open and under way.
- More trials run by Mansoura UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 46 participants (actual)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Abolazm, Mansoura University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07819032
- Sponsor's protocol ID
- R.24.06.2657
- Acronym
- EJHP-GLPVP
- Status last verified
- Sep 2026
- First submitted
- 7 Sep 2026
- Last updated
- 14 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Abolazm AE, El-Hefnawy AS, Laymon M, Shehab-El-Din AB, Elshal AM. Ejaculatory Hood Sparing versus Standard Laser Photoselective Vaporization of the Prostate: Sexual and Urodynamic Assessment through a Double Blinded, Randomized Trial. J Urol. 2020 Apr;203(4):792-801. doi: 10.1097/JU.0000000000000685. Epub 2019 Nov 25.
PubMed 31763948
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ejaculatory Hood Preserving GreenLight Laser Photoselective Vaporization of the Prostate, A Test Against Time
- ClinicalTrials.gov ID
- NCT07819032
- Acronym / sponsor ID
- EJHP-GLPVP / R.24.06.2657
- Conditions
- BPH/LUTS/Sexual Functions
- Keywords
- Ejaculatory Hood, laser prostatectomy, antegrade ejaculation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 46 participants (actual)
- Lead sponsor
- Mansoura UniversityUniversity, hospital or other
- Study start
- 6 Jun 2024 (actual)
- Primary completion
- 7 Sep 2026 (actual)
- Study completion
- 7 Sep 2026 (actual)
- First posted
- 14 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
long term evaluation of ejaculation preserving laser prostatectomy for BPH patients
Detailed description
We aimed to follow up our patients who were managed by ejaculation preserving GLPVP. we aimed to elucidate the long-term impact of EH preserving GL-PVP on both LUTS recurrence if any and the maintenance of adequate and satisfying ejaculatory functions 5 years after intervention compared to the last point of previous follow up (1 year after intervention).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 5 Years
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| standard green laser PVP | – | –long term follow up impact of standard GL.PVP on both LUTS and sexual functions |
| Ejaculatory hood preserving green laser PVP | – | –long term follow up impact of standard GL.PVP on both LUTS and sexual functions |
Who may qualify
- Ages
- 40 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- BPH patients managed by green laser prostatectomy
Key inclusion criteria (1 listed)
- all patients who were previously managed by green laser PVP in the past 5 years in our center
Key exclusion criteria (1 listed)
- death or patients who missed follow up
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
International prostate symptom score at 5 years
Time frame: 5 years after laser prostatectomy
the possible recurrence of lower urinary tract symptoms assessed by increased international prostate symptom score (higher score= recurrence).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2026.
- Results publication: PubMed 31763948Abolazm AE, El-Hefnawy AS, Laymon M, Shehab-El-Din AB, Elshal AM. Ejaculatory Hood Sparing versus Standard Laser Photoselective Vaporization of the Prostate: Sexual and Urodynamic Assessment through a Double Blinded, Randomized Trial. J Urol. 2020 Apr;203(4):792-801. doi: 10.1097/JU.0000000000000685. Epub 2019 Nov 25.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of BPH/LUTS/Sexual Functions, run by Mansoura University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
International prostate symptom score at 5 years (time frame: 5 years after laser prostatectomy). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07819032, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026; AzTrials last refreshed its copy on 8 Nov 2026.